Govt forms committee to examine WHO report on 66 kid deaths linked to 4 Indian syrups
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
The WHO had issued an alert on four India-made cough and cold syrups
The World Health Organisation (WHO), which recently issued a medical health alert against cough syrups manufactured by Indian firm Maiden Pharmaceuticals following the death of 66 children in Gambia, on October 29 informed the Drug Controller General of India (DGCI) that it collected 23 samples of medicines under reference for further testing and four samples were found to be contaminated with diethylene glycol/ ethylene glycol--an ingredient which may have contributed to the death of the children.
A day after the raid conducted by the joint team of the Drug Controller General of India (DCGI) and the Food and Drugs Administration (FDA) in Maiden Pharmaceutical Limited at the HSIIDC Kundli, the company owner refuted allegations against the firm and said no death was reported in The Gambia due t
A joint team of the Drug Controller General of India (DCGI) and the Food and Drugs Administration (FDA) continued with its investigation at Maiden Pharmaceuticals Limited at the HSIIDC, Kundli, for the second consecutive day today. A director-cum-owner of the company joined the investigation.